ID   UISO-MEL-23
AC   CVCL_ZL38
SY   UISO-Mel-23; MEL-23; University of Illinois Surgical Oncology-MELanoma-23
DR   IARC_TP53; 23798
DR   Wikidata; Q98133911
RX   PubMed=7872667;
RX   PubMed=8012659;
RX   PubMed=12894234;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.673-12G>T; Zygosity=Unspecified (PubMed=7872667).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 5
//
RX   PubMed=7872667;
RA   Rauth S., Kichina J.V., Green A.D., Bratescu L., Das Gupta T.K.;
RT   "Establishment of a human melanoma cell line lacking p53 expression
RT   and spontaneously metastasizing in nude mice.";
RL   Anticancer Res. 14:2457-2463(1994).
//
RX   PubMed=8012659; DOI=10.1007/BF02631396;
RA   Rauth S., Green A.D., Bratescu L., Das Gupta T.K.;
RT   "Chromosome abnormalities in metastatic melanoma.";
RL   In Vitro Cell. Dev. Biol. Anim. 30:79-84(1994).
//
RX   PubMed=12894234; DOI=10.1038/sj.onc.1206741;
RA   Kichina J.V., Rauth S., Das Gupta T.K., Gudkov A.V.;
RT   "Melanoma cells can tolerate high levels of transcriptionally active
RT   endogenous p53 but are sensitive to retrovirus-transduced p53.";
RL   Oncogene 22:4911-4917(2003).
//